Aurora Cannabis Net Income
| ACB Stock | USD 3.31 0.44 11.73% |
As of the 6th of February, Aurora Cannabis shows the Standard Deviation of 4.01, risk adjusted performance of (0.09), and Mean Deviation of 2.67. Aurora Cannabis technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Aurora Cannabis Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.7548 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 14.2 M | 14.9 M | |
| Net Income From Continuing Ops | 14.2 M | 14.9 M | |
| Net Loss | -1.5 B | -1.5 B | |
| Net Income Per Share | 0.03 | 0.04 | |
| Net Income Per E B T | 0.09 | 0.09 |
Aurora | Net Income | Build AI portfolio with Aurora Stock |
Analyzing Aurora Cannabis's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Aurora Cannabis's current valuation and future prospects.
Latest Aurora Cannabis' Net Income Growth Pattern
Below is the plot of the Net Income of Aurora Cannabis over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Aurora Cannabis financial statement analysis. It represents the amount of money remaining after all of Aurora Cannabis operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Aurora Cannabis' Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aurora Cannabis' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 15.76 M | 10 Years Trend |
|
Net Income |
| Timeline |
Aurora Net Income Regression Statistics
| Arithmetic Mean | (401,544,686) | |
| Geometric Mean | 11,223,712 | |
| Coefficient Of Variation | (217.73) | |
| Mean Deviation | 576,987,207 | |
| Median | (5,723,000) | |
| Standard Deviation | 874,274,210 | |
| Sample Variance | 764355.4T | |
| Range | 3.4B | |
| R-Value | (0.19) | |
| Mean Square Error | 786022.6T | |
| R-Squared | 0.04 | |
| Significance | 0.47 | |
| Slope | (32,815,085) | |
| Total Sum of Squares | 12229686.3T |
Aurora Net Income History
Other Fundumenentals of Aurora Cannabis
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Aurora Cannabis Net Income component correlations
Aurora Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Aurora Cannabis is extremely important. It helps to project a fair market value of Aurora Stock properly, considering its historical fundamentals such as Net Income. Since Aurora Cannabis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aurora Cannabis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aurora Cannabis' interrelated accounts and indicators.
Click cells to compare fundamentals
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aurora Cannabis. If investors know Aurora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Aurora Cannabis assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.95) | Earnings Share (1.09) | Revenue Per Share | Quarterly Revenue Growth 0.068 | Return On Assets |
Understanding Aurora Cannabis requires distinguishing between market price and book value, where the latter reflects Aurora's accounting equity. The concept of intrinsic value - what Aurora Cannabis' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Aurora Cannabis' price substantially above or below its fundamental value.
Understanding that Aurora Cannabis' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aurora Cannabis represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Aurora Cannabis' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Aurora Cannabis 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aurora Cannabis' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aurora Cannabis.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Aurora Cannabis on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Aurora Cannabis or generate 0.0% return on investment in Aurora Cannabis over 90 days. Aurora Cannabis is related to or competes with Alpha Teknova, Canopy Growth, Lifecore Biomedical, BioAge Labs, Ironwood Pharmaceuticals, OrganiGram Holdings, and High Tide. Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative ... More
Aurora Cannabis Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aurora Cannabis' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aurora Cannabis upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 26.49 | |||
| Value At Risk | (6.97) | |||
| Potential Upside | 3.57 |
Aurora Cannabis Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aurora Cannabis' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aurora Cannabis' standard deviation. In reality, there are many statistical measures that can use Aurora Cannabis historical prices to predict the future Aurora Cannabis' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.56) | |||
| Total Risk Alpha | (0.73) | |||
| Treynor Ratio | (1.24) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aurora Cannabis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Aurora Cannabis February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (1.23) | |||
| Mean Deviation | 2.67 | |||
| Coefficient Of Variation | (756.72) | |||
| Standard Deviation | 4.01 | |||
| Variance | 16.11 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (0.56) | |||
| Total Risk Alpha | (0.73) | |||
| Treynor Ratio | (1.24) | |||
| Maximum Drawdown | 26.49 | |||
| Value At Risk | (6.97) | |||
| Potential Upside | 3.57 | |||
| Skewness | 1.32 | |||
| Kurtosis | 7.83 |
Aurora Cannabis Backtested Returns
Aurora Cannabis secures Sharpe Ratio (or Efficiency) of -0.12, which signifies that the company had a -0.12 % return per unit of risk over the last 3 months. Aurora Cannabis exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aurora Cannabis' Risk Adjusted Performance of (0.09), mean deviation of 2.67, and Standard Deviation of 4.01 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.44, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Aurora Cannabis' returns are expected to increase less than the market. However, during the bear market, the loss of holding Aurora Cannabis is expected to be smaller as well. At this point, Aurora Cannabis has a negative expected return of -0.49%. Please make sure to confirm Aurora Cannabis' kurtosis, day median price, and the relationship between the potential upside and daily balance of power , to decide if Aurora Cannabis performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.33 |
Poor reverse predictability
Aurora Cannabis has poor reverse predictability. Overlapping area represents the amount of predictability between Aurora Cannabis time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aurora Cannabis price movement. The serial correlation of -0.33 indicates that nearly 33.0% of current Aurora Cannabis price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.33 | |
| Spearman Rank Test | -0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Aurora Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Aurora Cannabis reported net income of 15.76 M. This is 95.38% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 97.24% higher than that of the company.
Aurora Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aurora Cannabis' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aurora Cannabis could also be used in its relative valuation, which is a method of valuing Aurora Cannabis by comparing valuation metrics of similar companies.Aurora Cannabis is currently under evaluation in net income category among its peers.
Aurora Cannabis Current Valuation Drivers
We derive many important indicators used in calculating different scores of Aurora Cannabis from analyzing Aurora Cannabis' financial statements. These drivers represent accounts that assess Aurora Cannabis' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Aurora Cannabis' important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 365.2M | 304.0M | 298.7M | 346.6M | 311.9M | 296.3M | |
| Enterprise Value | 290.7M | 229.6M | 219.0M | 266.3M | 239.7M | 227.7M |
Aurora Cannabis ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Aurora Cannabis' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Aurora Cannabis' managers, analysts, and investors.Environmental | Governance | Social |
Aurora Cannabis Institutional Holders
Institutional Holdings refers to the ownership stake in Aurora Cannabis that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Aurora Cannabis' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Aurora Cannabis' value.| Shares | Dimensional Fund Advisors, Inc. | 2025-06-30 | 80.1 K | Ubs Group Ag | 2025-06-30 | 77.8 K | Td Asset Management Inc | 2025-06-30 | 69.5 K | Jane Street Group Llc | 2025-06-30 | 64.1 K | Millennium Management Llc | 2025-06-30 | 59 K | Advisorshares Investments, Llc | 2025-06-30 | 50.4 K | Two Sigma Advisers, Llc | 2025-06-30 | 46.2 K | Geode Capital Management, Llc | 2025-06-30 | 32.6 K | Wolverine Trading Llc | 2025-06-30 | 32 K | Tidal Investments Llc. | 2025-06-30 | 1.5 M | Goldman Sachs Group Inc | 2025-06-30 | 1.4 M |
Aurora Fundamentals
| Return On Equity | -0.16 | ||||
| Return On Asset | -0.0475 | ||||
| Profit Margin | (0.23) % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 206.47 M | ||||
| Shares Outstanding | 56.71 M | ||||
| Shares Owned By Institutions | 16.70 % | ||||
| Number Of Shares Shorted | 7.37 M | ||||
| Price To Earning | 46.94 X | ||||
| Price To Book | 0.54 X | ||||
| Price To Sales | 0.50 X | ||||
| Revenue | 343.29 M | ||||
| Gross Profit | 130.37 M | ||||
| EBITDA | 51.35 M | ||||
| Net Income | 15.76 M | ||||
| Cash And Equivalents | 439.14 M | ||||
| Cash Per Share | 1.46 X | ||||
| Total Debt | 103.98 M | ||||
| Debt To Equity | 0.41 % | ||||
| Current Ratio | 5.13 X | ||||
| Book Value Per Share | 5.94 X | ||||
| Cash Flow From Operations | 16 M | ||||
| Short Ratio | 3.14 X | ||||
| Earnings Per Share | (1.09) X | ||||
| Target Price | 6.37 | ||||
| Beta | 1.36 | ||||
| Market Capitalization | 187.71 M | ||||
| Total Asset | 847.77 M | ||||
| Retained Earnings | (6.33 B) | ||||
| Working Capital | 367.46 M | ||||
| Current Asset | 174.76 M | ||||
| Current Liabilities | 105.1 M | ||||
| Net Asset | 847.77 M |
About Aurora Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aurora Cannabis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aurora Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aurora Cannabis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Aurora Cannabis offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aurora Cannabis' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aurora Cannabis Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aurora Cannabis Stock:Check out For information on how to trade Aurora Stock refer to our How to Trade Aurora Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aurora Cannabis. If investors know Aurora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Aurora Cannabis assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.95) | Earnings Share (1.09) | Revenue Per Share | Quarterly Revenue Growth 0.068 | Return On Assets |
Understanding Aurora Cannabis requires distinguishing between market price and book value, where the latter reflects Aurora's accounting equity. The concept of intrinsic value - what Aurora Cannabis' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Aurora Cannabis' price substantially above or below its fundamental value.
Understanding that Aurora Cannabis' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aurora Cannabis represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Aurora Cannabis' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.